Expansion opportunities The center is expanding its international footprint with new offices in Indonesia and Southeast Asia, presenting a potential for regional partnerships, research collaborations, and cross-border healthcare programs.

Innovative therapies Active development of engineered T cell therapies and organoid tools signals opportunities to co-develop, license, or fund translational research, as well as joint clinical trial support and data collaboration.

Digital enablement Adoption of modern tech stack including Power BI, Azure, and Node.js indicates openness to data analytics, AI-driven insights, and digital health solutions for patient outcomes, operational efficiency, and research administration.

Financial scale With estimated revenue in the mid-range of tens of millions, the center can be a strategic partner for multi-year grants, sponsored research, and value-based collaborations that align with high-impact pediatric oncology goals.

Clinical leadership As a national hub consolidating top pediatric oncology expertise, there is potential for advisory, education, and capability-building partnerships, including training programs, consortium initiatives, and shared-standard initiatives.